Two-Tiered Medicine: Why Is Hydroxychloroquine Being Censored and Politicized?
By the Children’s Health Defense Team
In 2003, severe acute respiratory syndrome (SARS) induced a global panic—a dress rehearsal, as it were, for Covid-19 in 2020. Although SARS fatalities rapidly petered out (with an eventual worldwide tally of just 774 deaths), concerns about the potential for future spread of the SARS coronavirus (SARS-CoV) left doctors eager to identify effective drugs for treatment and prevention. In short order, researchers in Europe (2003 and 2004) and at the Special Pathogens Branch of the CDC (2005) published theoretical models and detailed in vitro findings about a drug offering likely “prophylactic and therapeutic advantage”: chloroquine (CQ).
Following these promising cell culture studies (cited hundreds of times in the scientific literature), researchers around the world continued to explore the antiviral potential of CQ and its more benign analog hydroxychloroquine (HCQ). A 2006…
View original post 566 more words